• $105,916.00
    Market Cap
  • -90.16%
    1-Year Change
  • Packaged Foods
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 75
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety

BioAdaptives' MyndMed™ nootropic supplement has been certified clean by TruShield™ Laboratory Services, meeting World Anti-Doping Agency (WADA) and UFC standards for athlete safety and supplement compliance.

08/20/2025, 11:54 AMGlobeNewswire

Peers

Statistics

More
Day Range
$0.005
$0.007
$0.006
1-Year Range
$0.006
$0.09
$0.006
Latest Close$0.006
Change
-$0.002 (-33.33%)
Volume1,780,261
Market Cap$105,916.00
Shares Outstanding12.0M
P/E (TTM)-0.06
Diluted EPS (TTM)-$0.14
Enterprise Value$488,617.00

Information as of 06/03/2026

Company Profile

$105,916.00
Market Cap
-$1.5M
Net Income
Sector: Consumer Defensive
Industry: Packaged Foods
2620 Regatta Drive, Las Vegas, NV, United States, 89128
702 659 8829

BioAdaptives, Inc. investigates, markets, and distributes natural plant, fungi, and algal-based products and medical devices for humans and animals. The company offers MyndMed for immediate cognitive enhancement, medium-term resilience and memory gains, and long-term neuroprotection and cognitive health; Zeranovia, a weight loss enhancer; Wynovia to help reduce the loss of lean muscle mass during dieting; and Xcellara, a regenerative wellness solution. It also provides canine products under the PawPa brand; dog chew products under the Regen brand; and Lung Flute, a medical device. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.

Key Executives

  • James Keener

Current Ownership Distribution

  • Insiders30.3M (100.00%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)
  • Other0 (0.00%)